Atomo Diagnostics, a company that specialises in rapid diagnostic tests, showcased its platform at the Arab Health Exhibition and Congress. The platform includes a range of tests for various diseases and conditions, including HIV and hepatitis, as well as a test for COVID-19. These tests are designed to be easy to use and provide accurate results in a short amount of time. The company aims to make these tests available to a wide range of users, including hospitals and clinics, as well as individuals.
John Kelly, CEO of Atomo Diagnostics, commented:
“Our innovative rapid test solutions deliver unmatched usability and simplicity in point-of-care testing, and have demonstrated excellent performance for both professional and home use. Our flagship HIV Self Test is prequalified by the WHO and registered in more than 20 countries. Beyond HIV, Atomo works with partners to commercialise tests on its devices for other applications, with commercialised tests delivering early detection of pregnancy and differentiating between viral and bacterial infection in primary care settings.
"Our unique devices and functionality are increasingly being recognised as a solution to decentralised testing needs and we continue to seek partners looking to improve the usability and performance of their POC tests. We are excited to be joining ABHI at this year’s Arab Health Exhibition where we look forward to showcasing our innovative products and technologies, as well as making new connections and forming new partnerships with global distributors.”
Read the full aricle by Med-Tech News here: med-technews.com